MENADIONE |
MENAPHTHENE |
MENAPHTHONE |
NSC-4170 |
KAPPAXIN |
VITAMIN K 3 |
KAYQUINONE |
KOLKLOT |
MITENON |
KARCON |
KANONE |
PANOSINE |
2-METHYL-1,4-NAFTOCHINON |
2-METHYL-1,4-NAPHTHALENDIONE |
MNQ |
KAERGONA |
VITAMIN K3 |
KLOTTONE |
KAYKOT |
K-THROMBYL |
AQUAKAY |
JUVA-K |
AQUINONE |
MENAQUINONE O |
2-METHYL-1,4-NAPHTHALENEDIONE |
KAPPAXAN |
MITENONE |
K-VITAN |
KATIV-G |
MENAQUINONE |
SYNKAY |
KAYKLOT |
VITAMIN K0 |
2-METHYL-1,4-NAPHTHOQUINONE |
KOAXIN |
2-METHYL-1,4-NAPHTHOCHINON |
KIPCA-OIL SOLUBLE |
KAREON |
MENAPHTONE |
2-METHYL-1,4-NAPHTHODIONE |
KAYNONE |
MENAPHTHON |
PROKAYVIT |
3-METHYL-1,4-NAPHTHOQUINONE |
VITAMIN K3: 1,4-DIHYDRO-1,4-DIOXO-2-METHYLNAPHTHALENE |
THYLOQUINONE |
2-METHYL-1,4-DIHYDRONAPHTHALENE-1,4-DIONE |
MENADION |
KIPCA |
HEMODAL |
pubchem.compound:4055 |
chembl:CHEMBL590 |
rxcui:6728 |
chemidplus:58-27-5 |
drugbank:00170 |
Drug Class | antifibrinolytic agents |
Year of Approval | approved before 1982 |
Drug Categories | quinones |
Drug Categories | phytol |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | for reducing EGFR-inhibitor-induced dermatological side effects |
Drug Categories | cytochrome p-450 cyp1a2 inducers (strength unknown) |
Drug Categories | cytochrome p-450 cyp2a6 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 enzyme inducers |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | vitamins (fat soluble) |
MENADIONE | DrugBank Drug Name |
58-27-5 | CAS Number |
Synkavite | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | nutraceutical |
MENADIONE | Primary Drug Name |
Year of Approval | approved before 1982 |
Drug Class | antifibrinolytic agents |
Drug Indications | for reducing EGFR-inhibitor-induced dermatological side effects |
Drug Class | Small Molecule |
FDA Approval | approved |
CHEMBL590 | ChEMBL Drug ID |
D03GET | TTD Drug ID |